Clinical Trial Update: Irinotecan and Etoposide in Treating Patients With Recurrent, Locally Advanced, or Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial investigates irinotecan and etoposide in patients with recurrent, locally advanced, or metastatic breast cancer. Results were posted in 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Camptosar (irinotecan)
• VePesid (etoposide)

Snippet

Sponsor: University of Arizona | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2013-08-21